Loading company…
SAS UroMems develops UroActive, an implantable device for severe stress urinary incontinence, from Grenoble, France.
Founded in 2011 in Grenoble, France, SAS UroMems develops UroActive, an implantable device that treats severe stress urinary incontinence in both genders and adapts automatically to each patient. The device is in clinical investigation. Hamid LAMRAOUI (CEO), Pierre Mozer and Stephane Lavallee co-founded the company. In May 2026 it raised USD 60 million in venture funding from ICONIQ Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in